Upcoming Events
Log In
Pricing
Free Trial

Screening Breast MR - High & Intermediate Risk Women

HIDE
PrevNext

0:00

So, I'm going to go through some of the

0:02

background history here about MR, and the

0:05

biggest trial really that I think, um,

0:07

well, the most important one early on, was the EVA trial.

0:10

This was Christiana Kuhl.

0:11

It was very famous for all sorts of breast MRI.

0:13

Mr.

0:13

Um, and this was, um, um, about

0:17

almost 700 asymptomatic women.

0:19

These were high-risk women, greater

0:21

than 20 percent lifetime risk

0:22

who underwent annual screens.

0:24

They had clinical breast exam, mammography,

0:26

ultrasound, and this was full protocol.

0:28

And were not abbreviated yet.

0:30

These were read independently of those studies

0:32

and in different combinations together.

0:34

And this was a really beautiful study and looked

0:37

at, um, you know, follow-up as well for outcomes.

0:41

So, mammography found

0:42

cancer detection yield of 1,000.

0:45

This is again a high-risk population.

0:48

Ultrasound 6, mammo plus ultrasound

0:50

because it's complimentary 7.

0:53

MRI almost 15, MRI plus ultrasound catches

0:57

that no more by adding ultrasound to MRI.

1:01

That's a very important note.

1:03

Mammography, however, adds to MRI, because

1:07

you can imagine very small early DCISs that

1:10

are only small areas of calcifications.

1:13

We may not see those as enhancing lesions on MRI.

1:16

Adding ultrasound again to MR

1:18

and mammography, no additional cancers detected.

1:22

So MR combined with mammography finds

1:25

the cancers, that's the way to go.

1:27

So, um, let me, I have something blocking.

1:31

There we go.

1:32

I hope you all can see, there was

1:33

something blocking my screen anyway.

1:35

Okay.

1:35

So, conclusion for screening high-risk

1:37

women again, high-risk women, these are the

1:39

outcomes there and you can see clearly that MR.

1:42

45 00:01:43,114 --> 00:01:44,635 plus mammography has the,

1:44

uh, the highest performance.

1:51

Then came the ACRIN 6666 trial.

1:54

This was screening ultrasound.

1:55

Wendy Berg's trial.

1:56

Very important.

1:57

Um, adding ultrasound screening to

2:00

women with non-actionable mammograms.

2:03

And these were mostly women with high risk.

2:07

Um, at least half of them had prior breast cancers

2:10

and the other half were considered high-risk

2:12

based on familial history and things like that.

2:15

Um, interesting at the very end of this,

2:17

after 3 rounds of non-actionable screens with the

2:20

ultrasound and mammography, MRI was added at the very end.

2:24

So let's look at these results.

2:26

Here's the mammography alone round 1 versus

2:29

round 2, and these are sequential rounds.

2:32

Ultrasound only, you can see the cancer detection.

2:35

Mammography plus ultrasound better

2:36

because they're complementary.

2:38

Supplemental ultrasound yielded

2:41

5.3 per 1,000 cancers, um, cancer

2:43

detection in the first year.

2:45

Additional in the second year, a seven

2:48

to eight absolute increase in recall.

2:50

Again, specificity is an issue with ultrasound.

2:53

And after three rounds of combined screening,

2:56

20% of the patients had short-term follow-ups.

2:59

Women hate short-term follow-ups.

3:01

Category threes. They hate them.

3:03

So let's see about the MRI.

3:05

So here's the mammography alone.

3:07

Cancer detection rate at 8.2.

3:08

80 00:03:08,640 --> 00:03:11,480 This is overall and this is mammography plus ultrasound.

3:11

It goes up a little bit.

3:13

Add the MR 26.1

3:14

for a difference of a decisional almost 15 per

3:17

1,000 screen cancer detection mammography plus MR again,

3:22

very, very good versus mammography alone MR alone.

3:25

So combining MRI and mammograms are the way to go.

3:32

After three rounds of negative mammography

3:33

ultrasound, 7 per 1,000 additional cancers.

3:38

That's about 1.5%.

3:39

91 00:03:40,574 --> 00:03:42,525 Again, these are high risk for women with prior

3:42

breast cancer history, a four times greater cancer

3:45

yield than adding just ultrasound to mammograms.

3:48

So ultrasound screening as a supplement is

3:50

very, very common, and it does find cancers,

3:53

but it's not nearly as impactful as MRI.

3:56

So no doubt, MR with mammography is the way to go.

3:59

Here's just an example.

4:00

This is a woman who's extremely dense.

4:03

Um, she had a negative mammogram.

4:05

She even had, um, an ultrasound.

4:07

And you can see the duration is

4:09

October of 2012 and then March of 2013.

4:14

Here's her MRI of the right.

4:15

Here's her MRI of the left so diffuse enhancement.

4:19

This is not something that might be

4:20

detected on ultrasound because it's larger

4:23

than the field of view, even whole breast

4:25

ultrasound, but diffuse diffuse enhancement.

4:29

And this was.

4:30

An extensive invasive ductal carcinoma.

4:34

So what about cancer biology?

4:36

Always important.

4:36

Are we just finding slow

4:38

growing, you know, low stage.

4:40

This was an important study by Janice

4:42

Sung et al., including Chris Comstock,

4:44

a retrospective review of high-risk women.

4:47

What kind of cancers were found

4:48

by these different modalities?

4:50

Most of them were detected by MR in this group.

4:53

Um, a smaller amount by mammography,

4:55

and there were actually 12 invasive,

4:57

I'm sorry, interval cancers as well.

5:00

And I love this graph, because what

5:02

you can see along the bottom is

5:04

increasing tumor histologic grade.

5:07

So worse, more aggressive.

5:09

DCIS.

5:10

Low grade is all the way there

5:11

on the left at the bottom.

5:12

Then it gets intermediate

5:13

grade DCIS, high grade DCIS.

5:16

Then we get microinvasive invasive

5:18

ductal carcinoma with a low grade,

5:20

intermediate grade, and high grade.

5:22

And look at these different curves.

5:24

The MR screening has, uh,

5:27

that's the mammogram line, sorry,

5:29

has decreasing, um, aggressive biologies.

5:33

Finds more DCIS

5:34

143 00:05:34,550 --> 00:05:34,720

5:34

145 00:05:35,280 --> 00:05:36,860 less high grade ones because those

5:36

high grade ones sometimes are round

5:38

balls like triple negative cancers.

5:40

But look at the MRI.

5:41

150 00:05:41,910 --> 00:05:42,320

5:42

increasing tumor histology.

5:44

And those are the ones we

5:45

really, really want to find.

5:46

I mean, we want to find them all in my mind,

5:48

but those aggressive tumors are the ones

5:51

between screens that can cause problems.

5:54

So more cancers with MRI.

5:55

159 00:05:55,730 --> 00:05:55,940

5:55

And more often invasive and higher

5:57

grade than those that mammography.

Report

Faculty

Emily F. Conant, MD

Professor of Radiology, Chief of Breast Imaging, Vice Chair of Faculty Development

Department of Radiology, University of Pennsylvania

Tags

Screening

Neoplastic

MRI

Diagnosis & Staging

Breast

© 2024 Medality. All Rights Reserved.

Contact UsTerms of UsePrivacy Policy